Enforcement record
承認 disclosure naming ロシュ・ダイアグノスティックス株式会社
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
承認
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
17 August 2022
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-YAKKIHO-ROSIYUDAI-202608182208
- Generated at
- 19 August 2026 at 07:08
- Record URL
- https://regbase.jp/en/enforcement/yakkiho-rosiyudaiagunosuteitukusu-20220817
1. Review Summary
| Disclosure name | ロシュ・ダイアグノスティックス株式会社 | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 17 August 2022 | Authority | Ministry of Health, Labour and Welfare |
| Law | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices | Action type | 承認 |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | ロシュ・ダイアグノスティックス株式会社 |
|---|
3. Enforcement Record
| Target name in disclosure | ロシュ・ダイアグノスティックス株式会社 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices / 承認 |
| Action / announcement date | Action: 17 August 2022 / Announcement: 5 May 2026 |
| English summary | Roche Diagnostics Corporation received approval under the Pharmaceutical and Medical Device Act (PMDA) on August 17, 2022, for the OTC designation of a COVID-19 antigen test kit. The approval process was expedited, and the product has begun online sales, indicating a swift progression in market availability. |
| Original Japanese text | インターネットを介しての販売も開始されている状況で、迅速に進んでいる状況です。 |
| Official source | https://www.mhlw.go.jp/stf/newpage_28612.html |
| Source archive | https://kiroku.today/a/b6c75c64b9hv28sk |
| Extraction / evidence timestamps | Extracted: 5 May 2026 at 09:00 / Evidence checked: 5 May 2026 at 09:00 / Archive captured: 28 April 2026 at 09:01 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming ロシュ・ダイアグノスティックス株式会社
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for ロシュ・ダイアグノスティックス株式会社
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- ロシュ・ダイアグノスティックス株式会社Japanese onlyOriginal: ロシュ・ダイアグノスティックス株式会社
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- 承認承認
- Action date
- 17 August 2022
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医療機器・体外診断薬
Violation
Roche Diagnostics Corporation received approval under the Pharmaceutical and Medical Device Act (PMDA) on August 17, 2022, for the OTC designation of a COVID-19 antigen test kit. The approval process was expedited, and the product has begun online sales, indicating a swift progression in market availability.
Show original Japanese text
インターネットを介しての販売も開始されている状況で、迅速に進んでいる状況です。
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-05-05T00:00:55.957+00:00
- Evidence checked
- 2026-05-05T00:00:55.957+00:00
- Archive captured
- 2026-04-28T00:01:32.613498+00:00
Show audit JSON
{
"record": {
"id": "bdb870a2-dc6a-43ea-b217-de332a32d03a",
"url": "https://regbase.jp/en/enforcement/yakkiho-rosiyudaiagunosuteitukusu-20220817",
"company_name_original": "ロシュ・ダイアグノスティックス株式会社",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "薬機法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "承認",
"en": "承認"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (ロシュ・ダイアグノスティックス株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/yakkiho-rosiyudaiagunosuteitukusu-20220817",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_28612.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/b6c75c64b9hv28sk",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_28612.html",
"archiveCapturedAt": "2026-04-28T00:01:32.613498+00:00",
"extractedAt": "2026-05-05T00:00:55.957+00:00",
"translatedAt": "2026-07-06T07:42:17.502+00:00",
"evidenceCheckedAt": "2026-05-05T00:00:55.957+00:00",
"generatedAt": "2026-08-18T22:08:39.747Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.